Is TREACE MEDICAL CONCEPTS, INC. (TMCI) Halal?

NASDAQ Healthcare United States $79M
✗ NOT HALAL
Confidence: 90/100
TREACE MEDICAL CONCEPTS, INC. (TMCI) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 75.4% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. TREACE MEDICAL CONCEPTS, INC. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 75.4%
/ 30%
81.9%
/ 30%
44.2%
/ 30%
2.33%
/ 5%
✗ NOT HALAL
DJIM 75.4%
/ 33%
81.9%
/ 33%
44.2%
/ 33%
2.33%
/ 5%
✗ NOT HALAL
MSCI 32.1%
/ 33%
34.9%
/ 33%
18.8%
/ 33%
2.33%
/ 5%
✗ NOT HALAL
S&P 75.4%
/ 33%
81.9%
/ 33%
44.2%
/ 33%
2.33%
/ 5%
✗ NOT HALAL
FTSE 32.1%
/ 33%
34.9%
/ 33%
18.8%
/ 50%
2.33%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-0.93
P/B Ratio
0.9
EV/EBITDA
-2.3
EV: $102M
Revenue
$213M
Growth: -9.0%
Beta
0.8
Low volatility
Current Ratio
4.3

Profitability

Gross Margin 79.8%
Operating Margin -9.5%
Net Margin -27.7%
Return on Equity (ROE) -58.9%
Return on Assets (ROA) -16.6%

Cash Flow & Balance Sheet

Operating Cash Flow-$16M
Free Cash Flow-$29M
Total Debt$72M
Debt-to-Equity82.3
Current Ratio4.3
Total Assets$191M

Price & Trading

Last Close$1.28
50-Day MA$1.88
200-Day MA$4.45
Avg Volume796K
Beta0.8
52-Week Range
$1.19
$8.55

About TREACE MEDICAL CONCEPTS, INC. (TMCI)

CEO
Mr. John T. Treace
Employees
450
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap
$79M
Currency
USD

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is TREACE MEDICAL CONCEPTS, INC. (TMCI) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), TREACE MEDICAL CONCEPTS, INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is TREACE MEDICAL CONCEPTS, INC.'s debt ratio?

TREACE MEDICAL CONCEPTS, INC.'s debt ratio is 75.4% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 32.1%.

What are TREACE MEDICAL CONCEPTS, INC.'s key financial metrics?

TREACE MEDICAL CONCEPTS, INC. has a market capitalization of $79M, and revenue of $213M. The company maintains a gross margin of 79.8% and a net margin of -27.7%. Return on equity stands at -58.9%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.